Stocks · Healthcare · Biotechnology
SL Science Holding Ltd SLBT
$1.57 -1.88% Close, Oct 2, 2026 · NASDAQ · Market cap $880.4M
High risk
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is 86% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 5%
How cheap the shares are relative to earnings, cash flow and their own history.
Strength and persistence of the price trend, including versus the S&P 500.
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 6%
- Maximum drawdown, 3 yearsBottom 24%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Return on invested capital | -153.7% | — | Bottom 5% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- 50-day average slope (20 days)
- -27.7%
- Distance from 50-day average
- -35.6%
- RSI (14)
- 33.7
- Relative volume
- 0.49×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 110.5%
- Current drawdown from 1-year high
- -85.8%
- Maximum drawdown, 3 years
- -85.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 11, 2026 | Sep 24, 2026 | -85.8% | 72 days | Not yet recovered |
| May 20, 2026 | May 21, 2026 | -15.5% | 1 days | 2 days (May 26, 2026) |
| Jun 2, 2026 | Jun 10, 2026 | -14.4% | 6 days | 1 days (Jun 11, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $880.4M
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $878,971 | $3.4M | $2.2M |
| Gross profit | $738,008 | $1.9M | $775,062 |
| Operating income | $96,828 | -$1.2M | -$3.8M |
| Net income | $399,035 | -$1.2M | -$3.8M |
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Operating cash flow | -$2.5M | $280,158 | -$1.9M |
| Capital expenditure | -$182,984 | -$7,970 | -$319,685 |
| Free cash flow | -$2.6M | $272,188 | -$2.2M |
| Dividends paid | $0 | $0 | $0 |
| Net share buybacks | $0 | $7.2M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.3M
- Total assets
- $2.8M
- Total liabilities
- $533,277
- Total debt
- $213,405
- Net debt
- -$1.0M
- Shareholders’ equity
- $2.3M
As of Dec 31, 2025 (filed Dec 31, 2025).
Short interest
- Shares sold short
- 26,771
- Days to cover
- 1.00
- Change vs previous report
- -28.9%
FINRA short interest, settlement date Sep 15, 2026.